Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Thrombocytopenia”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Not applicableEnded earlyNCT02050581
What this trial is testing

A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone

Who this might be right for
Idiopathic Thrombocytopenia Purpura
Weill Medical College of Cornell University 72
Not applicableEnded earlyNCT01615146
What this trial is testing

Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot

Who this might be right for
Myelodysplastic SyndromeLeukemia
Ottawa Hospital Research Institute 9
Very early researchStudy completedNCT04478227
What this trial is testing

TPO-Mimetic Use in Children for Hematopoietic Failure

Who this might be right for
Bone Marrow Failure DisordersAplastic AnemiaThrombocytopenia+2 more
Anjali Sharathkumar 15
Not applicableStudy completedNCT02922543
What this trial is testing

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Who this might be right for
Multiple Myeloma
Celgene 361
Testing effectiveness (Phase 2)Study completedNCT00195624
What this trial is testing

Alemtuzumab to Treat Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia, RefractorySevere Aplastic Anemia, Relapse
National Heart, Lung, and Blood Institute (NHLBI) 47
Testing effectiveness (Phase 2)Ended earlyNCT01676961
What this trial is testing

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+2 more
NYU Langone Health 5
Early research (Phase 1)Looking for participantsNCT06943937
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis (LN)Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd. 36
Very early researchLooking for participantsNCT06519565
What this trial is testing

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 6
Very early researchLooking for participantsNCT06337474
What this trial is testing

An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenia Alloimmune
Changzhou No.2 People's Hospital 9
Testing effectiveness (Phase 2)Study completedNCT00475423
What this trial is testing

MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 122
Testing effectiveness (Phase 2)Looking for participantsNCT05599880
What this trial is testing

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Relapsed/Refractory Immune Thrombocytopenia
Seoul National University Hospital 29
Not applicableStudy completedNCT01672151
What this trial is testing

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
First Affiliated Hospital of Suzhou Medical College 35
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Early research (Phase 1)Study completedNCT02948283
What this trial is testing

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

Who this might be right for
AnemiaFatigueFever+10 more
City of Hope Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT00303472
What this trial is testing

Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)

Who this might be right for
ThrombocytopeniaMDSMyelodysplastic Syndromes+1 more
Amgen 72
Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Early research (Phase 1)Looking for participantsNCT07315087
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

Who this might be right for
SLE - Systemic Lupus ErythematosusSSc-Systemic SclerosisIIM- Idiopathic Inflammatory Myopathies+3 more
Institute of Hematology & Blood Diseases Hospital, China 12
Large-scale testing (Phase 3)UnknownNCT02877212
What this trial is testing

Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Not applicableStudy completedNCT01933035
What this trial is testing

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Who this might be right for
Immune ThrombocytopeniaChemotherapy Induced ThrombocytopeniaMyelodysplasia+1 more
Beth Israel Medical Center 50
Load More Results